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ㅋ
Chronic intestinal pseudo-obstruction (CIPO) is a rare disorder characterized by a severe impairment of gastrointestinal pro-
pulsion in the absence of mechanical obstruction. We experienced a case of chronic pseudo-obstruction in the initial phase 
mimicking acute pseudo-obstruction, which was treated medically. This ongoing case was compared to another recurrent and 
intractable case successfully treated with surgery and diagnosed as hypoganglionosis. These two cases showed different clinical 
features and therapeutic approaches for CIPO; one with the first episode of CIPO mimicking Ogilvie’s syndrome; the other with 
recurrent episodes of CIPO with typical features. In conclusion, CIPO is a difficult disorder with various clinical manifestations 
and different treatment modalities, therefore individualized diagnostic and therapeutic approaches are needed. 
(J Neurogastroenterol Motil 2010;16:83-89)
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Introduction
Chronic intestinal pseudo-obstruction (CIPO) is a rare, de-
bilitating disorder characterized by obstructive symptoms mim-
icking mechanical obstruction without any lesion occluding the 
gut.
1 Pseudo-obstruction could occur either with acute or chronic 
onset. Acute intestinal pseudo-obstruction, so called Ogilvie’s 
syndrome, is the most common form. Acute intestinal pseudo-ob-
struction often occurs in critically ill patients or during the post-
operative period.
2,3 However, CIPO patients typically passes un-
recognized for long periods of time before the definitive diagnosis 
is established, so affected individuals are often unable to maintain 
normal body weight and/or become malnourished.
4 Further-
more, patients sometimes receive inadequate treatments or need-
less abdominal surgeries due to the delay in confirming the 
diagnosis.
5 Therefore, it is very important for physicians to un-
derstand the pathophysiology, clinical features and treatment of 
this rare but debilitating disorder. We experienced a case of 
chronic pseudo-obstruction in the initial phase, which mimicked Byoung Hwan Lee, et al
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Figure 1. Radiologic findings of 
acute pseudo-obstruction 
case. Marked gaseous dila-
tation of the colon in simple 
abdomen (A) and gaseous 
distension of the colon 
from cecum to sigmoid 
colon in the CT axial scan, 
with well traced entire colon 
without a definitive obs-
tructive lesion; narrowed 
segment is observed in the 
sigmoid colon (B). 
Figure 2. Colonoscopic finding in acute intestinal pseudo-obstruction. Marked dilation of colonic lumen without a mucosal or luminal lesion to 
cause mechanical obstruction (A); luminal kinking by gaseous distension is observed (B). 
an acute pseudo-obstruction, and treated through medical 
approach. He was compared to another recurrent and intractable 




38-year-old male patient visited Emergency Room for ab-
dominal pain and distension which were aggravated two days ago. 
Abdominal distension was developed 2 months ago but he did 
not visit any hospital since defecations with loose stools and gas 
passages were possible. He had no known history of any metabol-
ic, neurological, cardiovascular or pulmonary diseases, previous 
abdominal or pelvic surgeries, and no history of abdominal can-
cer, inflammatory processes or trauma. No concomitant medi-
cation was taken. Physical examination revealed marked abdomi-
nal distension with hyperactive bowel sound, and he complained 
of mild tenderness on the entire abdomen without any rebound Chronic Idiopathic Intestinal Pseudo-obstruction
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Figure 3. Follow-up radiologic fin-
ding after medical treat-
ment. Gaseous distension 
is somewhat decreased, 
especially in the ascending 
and descending colon after 
i.v. neostigmine (A). Recent 
follow-up image shows de-
creased gaseous distension 
in the transverse colon after 
oral erythromycin, but ileus 
is still remained above the 
sigmoid colon (B).
Figure 4. Radiologic and post-operative gross finding of chronic intestinal pseudo-obstruction case. Marked gaseous distension of the colon with 
profuse fecal materials from cecum to sigmoid colon was shown in the CT axial scan. However, the entire colon is well traced without 
a definitive obstructive lesion; narrowed segment is observed in the sigmoid colon (arrows) (A). Post operative gross findings shows 28 
cm length of dilated segment (red arrow) and 4.3 cm length of narrowed segment (blue arrow) which is observed distal to the dilated 
segment (B).
tenderness. There was no sign of scar on the abdomen. Vital sign 
was stable and no fever was checked. The laboratory findings 
showed a hemoglobin of 14.7 g/dL, White blood cells 5,310/mm
3 
and platelets 265,000/mm
3. The blood chemistry showed: a so-
dium of 142 mmol/L, potassium 3.6 mmol/L, chloride 105 
mmol/L, calcium 8.6 mg/dL and albumin 4.4 g/dL. Fasting glu-
cose level was 90 mg/dL. Amylase and lipase were 51 and 59 
mg/dL, respectively. Thyroid function test was normal; T3, free 
T4, and TSH were 0.7 ng/mL, 1.31 ng/dL, and 2.86 μIU/mL, 
respectively (all within normal range). There was no evidence of 
amyloidosis on colonoscopic biopsy. However, we did not per-
form tests for SLE or scleroderma because there were no clinical 
symptoms or physical signs of these diseases. Chest X-ray imag-
ing showed normal findings. Marked gaseous dilatation above 
the pelvic cavity was shown in the simple abdominal X-ray image 
(Fig. 1A). Abdominal computed tomography revealed a marked 
distension from the ascending colon to the sigmoid colon whereas 
the entire colon was well traced without a definite obstructive Byoung Hwan Lee, et al
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lesion. There was a narrowed segment in the sigmoid colon which 
was suggestive of transitional zone. No fluid collection or free air 
was shown in the abdominal cavity (Fig. 1B). Colonoscopy was 
performed for the evaluation of luminal lesions. Colonoscopy 
showed huge colonic dilatation (Fig. 2A) and kinking up to the 
cecum (Fig. 2B) but no obstructive, diverticular or mucosal 
lesions. Decompression with colonoscopic suction resulted in a 
decreased abdominal distension immediately. Randomized, mul-
tiple mucosal biopsies showed normal findings except mild ische-
mic changes due to the over-distension. Initially he was diag-
nosed as acute intestinal pseudo-obstruction, so called Ogilvie’s 
syndrome, and intravenous neostigmine was tried with EKG 
monitoring. After intravenous administration of neostigmine (2.5 
mg) for 1 hour, side effects such as bradycardia, hypotension, at-
rial fibrillation developed and continuous infusion was stopped. 
Simultaneously, there was a dramatic evacuation of flatus and 
loose stools (Fig. 3A). However, abdominal distension developed 
again in the following day, and neostigmine (i.v. 2.0 mg for 4 
hours) was retried cautiously. Again there were evacuations of 
gases and loose stools without any side effects occurring abdomi-
nal distension developed in the next following day similar to the 
first trial of neostigmine. The symptom was endurable and ordi-
nary activity was possible and the patient began to take 500 mg of 
erythromycin three times per day. Although abdominal dis-
tension was sustained in spite of the maintenance of erythromycin 
(Fig. 3B), gas passages and defecations were possible every day 
and the degree of distension was rather mild. After two months 
he stopped taking erythromycin and started to take metoclopra-
mide instead. He is doing well until now about five months from 
the discharge.
Case 2
43 year-old female visited Emergency Room for recurrent 
abdominal distension and pain. She suffered from constipation 
for 10 years which repeatedly aggravated and improved. From 
two months ago, it became worse and didn’t improve. Physical 
examination in the emergency unit showed marked abdominal 
distension and mild abdominal tenderness. Bowel sound was 
mildly increased by the auscultation. There was no sign of scar on 
her abdominal wall. Vital signs were stable and no fever was 
detected. The laboratory findings showed a hemoglobin of 12.6 
g/dL, platelets and white blood cells were 229 × 10
3/μL and 
16.19 × 10
3 /μL, respectively. The blood chemistry showed: a 
sodium of 136 mmol/L, potassium 4.1 mmol/L, chloride 100 
mmol/L, calcium 8.7 mg/dL and albumin 4.4 g/dL. Amylase 
was 21 mg/dL and other laboratory findings were within normal 
range. There was no history of any metabolic, neurological, car-
diovascular or pulmonary diseases, previous abdominal or pelvic 
surgeries, and no history of abdominal cancer, inflammatory 
processes or trauma. No concomitant medication was taken. She 
never drank alcohol or smoked without any specific family 
history. After the admission, detailed medical tests were per-
formed to find out the causes of abdominal pain and distention. 
There was no evidence of metabolic diseases such as diabetes, 
porphyria, or amyloidosis. Chest X-ray imaging showed normal 
findings. Marked gaseous distension in the colon, especially in 
the descending colon was seen in the simple abdominal X-ray 
image. Colon transit time test showed a delayed transit especially 
in the left colon. Anorectal manometric finding was normal. 
Abdominal computed tomography scan showed marked dis-
tension in the left colon and the sigmoid colon, but there was no 
specific lesion to induce mechanical obstruction or no fluid col-
lection or free air in the peritoneal cavity (Fig. 4A). These radio-
logic and functional test suggested colonic pseudo-obstruction at 
the sigmoid colon level. Colonoscopy showed marked dilatation 
of the left and sigmoid colon, with non-specific ulcers in the 
transverse colon and rectum. Biopsies on ulcer lesions and ran-
dom colonic areas showed non-specific changes. Under the im-
pression of CIIPO surgical approach was chosen due to the re-
current symptoms and disturbed quality of life. Subtotal colec-
tomy was performed. Dilated segment was 28 cm long and 4.3 
cm length of narrowed segment was observed distal to the dilated 
segment (Fig. 4B). Markedly decreased number of mature 
myenteric ganglion cells, immature ganglion cells and decreased 
size of gangions in the myenteric plexus were observed in the nar-
rowed segment (Fig. 5A). Immunoreactivities for c-Kit (Fig. 
5B), synaptophysin (Fig. 5C), and Bcl-2 were markedly de-
creased in the myenteric plexus of the narrowed segment (Fig. 
5D), in which the pathologic findings confirmed hypoganglio-
nosis as the cause of pseudo-obstruction. She is under a good nu-
tritional status and symptoms have not recurred for 2 years after 
the surgery. 
Discussion
Intestinal pseudo-obstruction is a disease characterized by 
failure of intestinal propulsion without a definite cause for me-
chanical obstruction. This disorder presents with a wide spec-
trum of clinical manifestations in respect to onset time of either 
acute or chronic and to the etiology as idiopathic or secondary. Chronic Idiopathic Intestinal Pseudo-obstruction
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Figure 5. Pathologic finding of hypoganglionosis. Markedly decreased number of mature myenteric ganglion cells and decreased size (arrow) of 
ganglion are seen in the narrowed segment (H&E ×100) (A). Decreased expression of synaptophysin (B), c-Kit (C), and Bcl-2 by 
immunohistochemistry in the myenteric plexus (arrow) (×100) (D) is consistent with hypoganglionosis.
Acute intestinal pseudo-obstruction, also known as Ogilvie’s syn-
drome, often occurs in hospitalized patients and is associated with 
a wide variety of medical and surgical conditions.
2,3 Most of acute 
intestinal pseudo-obstruction occur in the colon and respond to 
conservative medical treatment, although perforation develops in 
a small number of patients with high mortality rate.
6 Treatment 
modality such as medical therapy, colonoscopic decompression, 
or surgery should be individualized based on the severity of the 
patient’s clinical status.
3 
In the first case, acute and first onset of pseudo-obstruction 
was developed and the patient was initially diagnosed as Ogilvie’s 
syndrome. At first, the patient was evaluated for the possible 
causes of acute pseudo-obstruction and colonoscopic decom-
pression was applied to the patient. No specific cause for acute 
pseudo-obstruction was found in spite of the comprehensive tests. 
Medical therapies such as neostigmine and erythromycin were 
only partially effective to the patient. Currently, the patient has 
been relatively doing well but mild sub-occlusive symptoms and 
signs were sustained during 5 months of follow-up period. As a 
result, the patient was considered to have undergone the first epi-
sode of CIPO. In the adult population, the first attack of pseu-
do-obstruction is often accompanied by a long history of non-spe-
cific, progressive symptoms like severe constipation. But an acute 
onset of the disease mimicking Ogilvie’s syndrome also occurs in 
one-fourth of the cases as the first case patient.
7
CIPO develops in either idiopathic or secondary form and 
the former comprises the majority of cases. In one study, systemic 
or metabolic causes of the disease were identified in only 4 of 77 Byoung Hwan Lee, et al
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CIPO patients.
7 Nevertheless, investigation of any secondary 
causes is necessary since correction of the secondary causes might 
be the only chance for cure of the CIPO. Many different diseases 
affect the control mechanisms of intestinal function, including in-
trinsic and extrinsic neural system as well as muscular system.
4 
The secondary causes that impair extrinsic nervous system can 
occur centrally or peripherally. The diseases affecting central 
nervous system are Parkinson syndrome, Shy-Drager syndrome, 
stroke, encephalitis, and neoplasm, whereas peripheral nervous 
system involves diabetes neuropathy, other neuropathies such as 
Hirschsprung, Chagas, and Von Reckling-hausen, as well as par-
aneoplastic syndromes, autoimmune diseases, or viral infections.
4 
Systemic muscular disorders like myotonic dystrophy and pro-
gressive systemic sclerosis could provoke damage to the intestinal 
smooth muscle cells and can also be the secondary causes of 
CIPO.
4 Collagen vascular disease, Ehlers-Danlos syndrome, je-
junal diverticulosis and radiation enteritis can be responsible for 
both neuronal and myogenic impairment.
4 Furthermore, hypo-
thyroidism, hypoparathyroidism, and celiac disease were reported 
to be the secondary causes of CIPO, even if the underlying mech-
anism remains undetermined.
4
Chronic idiopathic intestinal pseudo-obstruction (CIIPO) is 
diagnosed when no underlying cause is found in spite of the de-
tailed and thorough medical examination. Most cases of CIIPO 
in adults occur as sporadic forms, but some familial clusters were 
also reported as autosomal dominant, autosomal recessive or 
X-linked transmission.
8 In the present report, both patients were 
diagnosed as CIIPO without known causes for the secondary 
form of CIPO after the full examinations. Usually CIIPO is 
classified as neuropathic, mesenchymopathic and myopathic 
based on the pathogenesis affecting the enteric nervous system or 
smooth muscle cells,
4,5 so the full-thickness biopsies of intestinal 
wall are mandatory to define the underlying mechanisms of 
CIIPO. Furthermore, neuropathic form of CIIPO is classified 
as degenerative or inflammatory based on the mechanism of dam-
age to the enteric nervous system. Inflammatory neuropathies are 
diagnosed by infiltrations of dense inflammatory cells and dam-
ages to the myenteric plexus. Inflammatory cells in the myenteric 
plexus could be observed as lymphocyte predominant 
(lymphocytic myenteric ganglionitis) or eosinophil predominant 
(eosinophilic ganglionitis).
9,10 Autoimmune mechanism is con-
sidered to involve in lymphocytic myenteric ganglionitis with sev-
eral cases reported with positivity for anti-HuD anti-neuronal 
antibodies.
11 Degenerative neuropathies are characterized by de-
generation and loss of intrinsic neurons of the myenteric plexus.
4 
Typical pathologic findings reported in neurodegenerative 
CIIPO include various qualitative (neuronal swelling, intra-
nuclear inclusions, axonal degeneration and others) and quantita-
tive lesions (especially hypoganglionosis).
4 Bcl-2 protein is widely 
expressed in the peripheral nervous system and is considered to 
play a major role in neuronal survival. In severe form of degener-
ative CIIPO, Bcl-2 protein is markedly reduced in the myenteric 
plexus as the second case patient. This pathologic finding sug-
gests apoptosis in association with loss of ganglion cells in the 
myenteric plexus.
9 In the second case patient, total colectomy was 
performed because of the recurrent, sub-occlusive events and on-
going severe constipation. The histological exam revealed 
marked decrease of ganglion cells in the myenteric plexus and de-
creased immunoreactivity for c-Kit, synaptophysin, and Bcl-2 
confirming the diagnosis of hypoganglionosis. 
In the first case, mild sub-occlusions were sustained in the ra-
diologic exams with mild abdominal distension. We assume this 
patient could follow the clinical course of the second case which 
had shown the typical course of CIIPO. In the acute, sub-occlu-
sive episodes of CIIPO, treatment should be the same as the me-
chanical obstruction with proper decompression, correction of 
fluid and electrolytes imbalance and appropriate nutritional 
support. Furthermore, erythromycin, somatostatin and neo-
stigmine could aid the gastrointestinal motility, control visceral 
sensitivity and decrease the duration of sub-occlusive 
episodes.
4,12,13 Erythromycin enhances upper gastrointestinal 
motility with a specific agonist action on the motilin receptors.
12 
Octerotide increases intestinal motility and decreases bacterial 
overgrowth.
13 Combination of erythromycin and octreotide could 
be useful in controlling both the gastric emptying and the in-
testinal motility.
14 Neostigmine is effective in Ogilvie’s syn-
drome
15 and also in acute symptomatic relief of sub-occlusive epi-
sodes in CIIPO as in our case. Other medical options considered 
in the treatment of CIIPO are prokinetics, antibiotics, steroid 
and immunosuppressive agents.
4 
The effect of surgery is limited since CIIPO often involves 
the entire gastrointestinal tract with a progressive nature.
16 As 
surgical approach can aggravate the underlying condition, it 
should be reserved for only carefully selected patients. However, 
surgical resection such as colectomy should be considered, espe-
cially in hypoganglionosis,
17,18 as in the second case patient. In 
our hospital, five patients among 7 CIIPO were confirmed as hy-
poganglionosis during the last 6 years and all of them are doing 
well after the colectomy. Although the cases are few in numbers, 
these results suggest that hypoganglionosis is a frequent cause of Chronic Idiopathic Intestinal Pseudo-obstruction
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CIIPO in Korea and colectomy offers a curable opportunity be-
fore bowel transplantation or death in the intractable cases, which 
is somewhat different from Western society. 
In conclusion, we experienced two cases of CIIPO with dif-
ferent clinical features and treatment approaches. In the first case, 
the clinical feature was regarded as the first episode of CIPO 
mimicking Ogilvie’s syndrome. Patient was successfully treated 
by medical approach in the acute stage with partial response. This 
patient could experience the recurrent and progressive nature of 
CIIPO. In the second case patient, typical clinical feature with 
recurrent episodes of CIIPO was shown, and she was success-
fully treated by total colectomy and was confirmed as hypo-
ganglionosis, suggesting colectomy as a considerable and effec-
tive therapeutic option in the intractable and debilitating cases of 
hypoganglionosis. 
References
1. Faulk DL, Anuras S, Christensen J. Chronic intestinal pseudoo-
bstruction. Gastroenterology 1978;74:922-931.
2. Ogilvie H. Large-intestine colic due to sympathetic deprivation; a 
new clinical syndrome. Br Med J 1948;2:671-673.
3. Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon 
(Ogilvie's syndrome). An analysis of 400 cases. Dis Colon Rectum 
1986;29:203-210.
4. Antonucci A, Fronzoni L, Cogliandro L, et al. Chronic intestinal 
pseudo-obstruction. World J Gastroenterol 2008;14:2953-2961.
5. Stanghellini V, Cogliandro RF, de Giorgio R, Barbara G, Salvioli B, 
Corinaldesi R. Chronic intestinal pseudo-obstruction: manifes-
tations, natural history and management. Neurogastroenterol Motil 
2007;19:440-452.
6. Rex DK. Colonoscopy and acute colonic pseudo-obstruction. 
Gastrointest Endosc Clin N Am 1997;7:499-508.
7. Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history 
of chronic idiopathic intestinal pseudo-obstruction in adults: a single 
center study. Clin Gastroenterol Hepatol 2005;3:449-458.
8. De Giorgio R, Camilleri M. Human enteric neuropathies: morphol-
ogy and molecular pathology. Neurogastroenterol Motil 2004;16: 
515-531.
9. De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V. Advances in 
our understanding of the pathology of chronic intestinal pseu-
do-obstruction. Gut 2004;53:1549-1552.
10. Schappi MG, Smith VV, Milla PJ, Lindley KJ. Eosinophilic myen-
teric ganglionitis is associated with functional intestinal obstruction. 
Gut 2003;52:752-755.
11. Caras S, Laurie S, Cronk W, Tompkins W, Brashear R, McCallum 
RW. Case report: pancreatic cancer presenting with paraneoplastic 
gastroparesis. Am J Med Sci 1996;312:34-36.
12. Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treat-
ment of chronic intestinal pseudo-obstruction: description of six cases 
with a positive response. Aliment Pharmacol Ther 2004;19:687-694.
13. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on in-
testinal motility and bacterial overgrowth in scleroderma. N Engl J 
Med 1991;325:1461-1467.
14. Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide 
and erythromycin on idiopathic and scleroderma-associated intestinal 
pseudoobstruction. Dig Dis Sci 1995;40:1892-1901.
15. Turegano-Fuentes F, Munoz-Jimenez F, Del Valle-Hernandez E, 
et al. Early resolution of Ogilvie's syndrome with intravenous neo-
stigmine: a simple, effective treatment. Dis Colon Rectum 1997; 
40:1353-1357.
16. Kim HY, Kim JH, Jung SE, Lee SC, Park KW, Kim WK. Surgical 
treatment and prognosis of chronic intestinal pseudo-obstruction in 
children. J Pediatr Surg 2005;40:1753-1759.
17. Georgescu EF, Vasile I, Georgescu AC. Intestinal pseudo-ob-
struction--a rare condition with heterogeneous etiology and un-
predictable outcome. A case report. J Gastrointestin Liver Dis 
2008;17:77-80.
18. Jung YJ, Kim YS, Lee KH, et al. A case of chronic idiopathic in-
testinal pseudoobstruction. Korean J Gastroenterol 1999;34:843- 
848.